Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE965.8028.05 (+2.99 %)

PREV CLOSE ( ) 937.75

OPEN PRICE ( ) 949.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8475

TODAY'S LOW / HIGH ( )949.10 980.00

52 WK LOW / HIGH ( )551 1024.9

NSE963.6025.85 (+2.76 %)

PREV CLOSE( ) 937.75

OPEN PRICE ( ) 956.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 963.60 (359)

VOLUME 321571

TODAY'S LOW / HIGH( ) 952.55 980.00

52 WK LOW / HIGH ( )513.05 1025

Quarters

Select year

( in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

11946.46

12208.31

11197.36

11903.93

Total Expenditure

9587.01

9892.64

9016.62

9725.25

PBIDT (Excl OI)

2359.45

2315.67

2180.74

2178.68

Other Income

1068.62

271.4

85.83

119.79

Operating Profit

3428.07

2587.07

2266.57

2298.47

Interest

433.79

461.27

474.6

503.22

Exceptional Items

-32.99

-87.72

-83.67

-274.15

PBDT

2961.29

2038.08

1708.3

1521.1

Depreciation

506.23

496.43

488.86

488.6

Profit Before Tax

2455.06

1541.65

1219.44

1032.5

Tax

373.53

215.93

164.5

207.59

Provisions and contingencies

Profit After Tax

2081.53

1325.72

1054.94

824.91

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

2081.53

1325.72

1054.94

824.91

Minority Interest

-60.15

-39.9

-59.85

-34.24

Shares of Associates

-0.31

-10.48

0.99

31.27

Other related items

Misc. Expenses Written off

Consolidated Net Profit

2021.07

1275.34

996.08

821.94

Equity Capital

921.73

921.63

Face Value (IN RS)

Reserves

Calculated EPS

21.92

13.83

10.80

8.91

Calculated EPS (Annualised)

87.70

55.34

43.23

35.67

No of Public Share Holdings

66491446

66084135

66084869

% of Public Share Holdings

72.14

71.7

PBIDTM% (Excl OI)

19.75

18.96

19.47

18.30

PBIDTM%

28.69

21.19

20.24

19.30

PBDTM%

24.78

16.69

15.25

12.77

PBTM%

20.55

12.62

10.89

8.67

PATM%

17.42

10.85

9.42

6.92

Notes

Risk Disclosures on Derivatives

Quarterly Results

STRIDES PHARMA SCIENCE LTD.